Liraglutide Acetate – Aliquot, 3.5mg
Data Sheet
| Application | GLP-1 receptor agonist |
| CAS | 204656-20-2 |
| Molar Mass | 3751 g/mol |
| Chemical Formula | C172H265N43O51 |
| Amino Acid Sequence | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
| Synonyms | Liraglutide, 204656-20-2, NN2211, Victoza, NN-2211, Liraglutida, Liraglutidum, NN 2211, Liraglutidum [INN-Latin], Liraglutida [INN-Spanish], UNII-839I73S42A, HSDB 8205, Liraglutide (rDNA origin), NNC 90-1170, CHEMBL4084119, Saxenda |
| Storage | Store at ≤4°C, tightly sealed, away from heat, light and moisture |
| Solubility | Soluble in water |
| Organoleptic Profile | Fine white powder in 3mL glass aliquot |
| Composition | Each aliquot contains Liraglutide, Acetate |
| Specification | Liraglutide content (per aliquot): Liraglutide 3.5mg ±10% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
GLP-1 Analogue Peptide for Metabolic and Endocrine Research
Liraglutide Acetate is a research-grade GLP-1 analogue peptide widely studied for its potential relevance in incretin signaling, metabolic regulation pathways, glucose homeostasis research, and appetite-associated endocrine models. As a well-established peptide in metabolic science, Liraglutide has attracted significant scientific interest in studies involving insulin-associated signaling, energy balance pathways, and cardiometabolic research.
Researchers have investigated Liraglutide in models involving GLP-1 receptor-mediated signaling, metabolic efficiency pathways, appetite regulation research, and pancreatic-endocrine mechanisms. Its investigational profile has made it a notable compound in peptide and metabolic research science.
Supplied as a laboratory-grade aliquot for analytical and research applications.
Common Research Areas
- GLP-1 Receptor Signaling Research
- Metabolic Regulation Studies
- Glucose Homeostasis Investigation
- Appetite and Energy Balance Models
- Peptide Metabolic Research
How Liraglutide Works
Liraglutide has been studied for its potential interaction with pathways associated with GLP-1 receptor signaling, metabolic regulation, and endocrine control. Researchers have explored its relevance in models involving incretin-mediated mechanisms, appetite-associated signaling, and glucose regulatory pathways.
Its metabolic peptide profile has made it a recurring subject in advanced endocrine research.
Research Overview
Liraglutide has been investigated across a range of research models involving metabolism, endocrine signaling, and energy regulation pathways.
Areas of scientific interest include:
- GLP-1 pathway studies
- Glucose regulation investigations
- Metabolic signaling research models
- Appetite regulation studies
- Endocrine mechanism research
Its broad research relevance continues to make it a notable compound in metabolic science.
Liraglutide vs Related Compounds
Liraglutide vs Semaglutide
Liraglutide is often researched as a foundational GLP-1 analogue, while Semaglutide has drawn interest in extended-acting incretin pathway investigations.
Liraglutide vs Retatrutide
Retatrutide is associated with multi-receptor agonist research, whereas Liraglutide is more specifically tied to GLP-1 receptor pathway studies.
Frequently Asked Questions
What is Liraglutide studied for?
It is commonly researched in GLP-1 signaling, metabolic regulation, glucose homeostasis, and appetite-associated models.
What type of compound is Liraglutide Acetate?
Liraglutide is classified as a GLP-1 analogue research peptide.
How should Liraglutide be stored?
Lyophilized peptide aliquots are generally stored refrigerated according to laboratory handling protocols.
